Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

AIDS Research and Human Retroviruses

Volumn 12, Issue 7, 1996, Pages 585-592

  Harrer, Thomas ^a   Harrer, Ellen ^a   Kalams, Spyros A ^a   Elbeik, Tarek ^b   Staprans, Silvija I ^b   Feinberg, Mark B ^b,c   Cao, Yunzhen ^d   Ho, David ^d   Yilma, Tilahun ^e   Caliendo, Angela M ^a   Johnson, R Paul ^a   Buchbinder, Susan P ^f   Walker, Bruce D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GLADSTONE INSTITUTES   (United States)

^d AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f AIDS Office San Francisco   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CROSS REACTING ANTIBODY; NEUTRALIZING ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL;

EID: 0029877833     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.585     Document Type: Article

References (34)

1. Lui KJ, Darrow WW, and Rutherford GW: A model-based estimate of the mean incubation period of AIDS in homosexual men. Science 1988;240:1333-1335.
2. Hendriks JC, Mdeley GF, van Griensven GJ, Coutinho RA, Histerkamp SH, and van Druten HA: The treatment-free incubation period of AIDS in a cohort of homosexual men. AIDS 1993;7:231-239.
3. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, and Holmberg SD: Long-term HIV-1 infection without immunologic progression. AIDS 1994;8:1123-1128.
4. Learmont J, Tindall B, Evans L, Cunningham A, Cunningham P, Wells J, Penny R, Kaldor J, and Cooper DA: Long-term symptomless HIV-1 infection in recipients of blood products from a single donor [see comments]. Lancet 1992;340(8824):863-867.
5. Greenough TC, Somasundaran M, Brettler DB, Hesselton RM, Alimenti A, Kirchhoff F, Panicali D, and Sullivan JL: Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1994;10(4):395-403.
6. Schwartz D, Sharma U, Busch M, Weinhold K, Matthews T, Lieberman J, Birx D, Farzedagen H, Margolick J, Quinn T, Davis B, Bagasra O, Pomerantz R, and Viscidi R: Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. AIDS Res Hum Retroviruses 1994;10:1703-1711.
7. Shrager LK, Young JM, Fowler MG, Mathieson BJ, and Vermund SH: Long-term survivors of HIV-1 infection: Definitions and research challenges. AIDS 1994;8(suppl. 1):S95-S108.
8. Cao Y, Qin L, Zhang L, Safrit J, and Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332(4):201-208.
9. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, Montefiori D, Orenstein JM, Fox C, Schrager LK, et al.: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332 (4):209-216.
10. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, and Desrosiers RC: Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995;332(4):228-232.
11. Klein MR and van Baalen CA: Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1356-1372.
12. Rinaldo C, Huang X-L, Fan Z, Ding M, Beltz L, Panicali D, Mazzara G, Liebmann J, Cottrill M, and Gupta P: High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 1995;69(9):5838-5842.
13. Ferbas J, Kaplan AH, Hausner MA, Hultin LE, Matud JL, Zhiyuan L, Panicali DL, Nerng-Ho H, Detels R, and Giiorgi JV: Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis 1995;172:329-339.
14. Walker BD, Flexner C, Birch LK, Fisher L, Paradis TJ, Aldovini A, Young R, Moss B, and Schooley RT: Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type I. Proc Natl Acad Sci USA 1989;86(23):9514-9518.
15. Johnson RP, Trocha A, Yang L, Mazzara GP, Panicali DL, Buchanan TM, and Walker BD: HIV-1 gag specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J Immunol 1991;147(5):1512-1521.
16. Wong JT and Colvin RB: Bi-specific monoclonal antibodies: Selective binding and complement fixation to cells that express two different surface antigens. J Immunol 1987;139(4):1369-1374.
17. Wilson CC, Wong JT, Girard D, Merril DP, Dynan M, An D, Kalams SA, Johnson RP, Hirsch MS, D'Aquila RT, and Walker BD: Ex vivo expansion of CD4+ lymphocytes from HIV-1 infected persons in the presence of combination antiretroviral therapy. J Infect Dis 1995;172:88-96.
18. Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, D'Aquila RT, Kurnick JT, Walker BD: Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med 1994;179(4):1261-1271.
19. Johnson V: Evaluation of candidate HIV-1 agents in vitro. In: Techniques in HIV Research (Aldovini A and Walker B, eds.) Stockton Press, New York, 1990.
20. Ho DD, Moudgil T, and Alam M: Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321(24):1621-1625.
21. Mulder J, McKinney N, Christopherson C, Sninsky L, Greenfield L, and Kwok S: Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection. J Clin Microbiol 1994;32(2):292-300.
22. Boom R, Sol CJA, Salimans M, Jansen CL, Wertheim-van Dillen PME, and van der Noordaa J: Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28(3):495-503.
23. Dewar RL, Highbarger HC, Sarmiento MD, Todd JA, Vasudevachari MB, Davey RT, Kovacs JA, Salzman NP, Lane HC, and Urdea MS: Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis 1994;170:1172-1179.
24. Jassoy C, Johnson RP, Navia BA, Worth J, and Walker BD: Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS de-mentia complex. J Immunol 1992;149:3113-3119.
25. Lubaki MN, Egan MA, Siliciano RF, Weinhold KJ, and Bollinger RC: A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res Hum Retroviruses 1994;10(11):1427-1431.
26. Gotch FM, Nixon DF, Alp N, McMichael AJ, and Borysiewicz LK: High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immunol 1990;2(8):707-712.
27. Koup RA, Pikora CA, Luzuriaga K, Brettler DB, Day ES, Mazzara GP, and Sullivan JL: Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: In vitro quantitation of effector cell populations with p17 and p24 specificities. J Exp Med 1991;174(6): 1593-600.
28. 27a. Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinburg MB, Buchbinder SP, and Walker BD: Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection: Breath and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol; in press.
29. Zinkernagel RM and Hengartner H: T-cell-mediated immunopathology versus direct cytolysis by virus: Implications for HIV and AIDS. Immunol Today 1994;15(6):262-268.
30. Koenig S, Conley AJ, Brewah YA, Jones GM, Leath S, Boots LJ, Davey V, Pantaleo G, Demarest JF, Carter C, Wannebo C, Yanelli JR, Rosenberg SA, and Lane HC: Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient 1wads to selection for mutant HIV variants and subsequent disease progression. Nature Med 1995;1(4):330-336.
31. Battegay M, Moskophides D, Waldner H, Bruendler A, Fueng-Leung W, Mak TW, Hengartner H, and Zinkemagel RM: Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. J Immunol 1993;151:5408-5415.
32. Borrow P, Evans CF, and Oldstone MBA: Virus-induced immune suppression: Immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J Virol 1995;69:1059-1070.
33. Moskophidis D and Zinkernagel RM: Immunobiology of CTL escape mutants of LCMV. J Virol 1995;69:2187-2193.
34. Nowak M, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdam S, Klenerman P, Kocppe B, Sigmund K, Bangham CRM, and McMichael AJ: Antigeneic oscillations and shifting immunodominance in HIV-1 infections. Nature (London) 1995;375:606-611.